Content
All Posts > Content under
Bank Analysis On Why Bitcoin Can't Serve As An Inflation Hedge
Article By:
Benzinga
Read
Saturday, May 7, 2022 6:24 PM EDT
One of the largest banks in the U.S., Bank of America Corp, has recently stated that Bitcoin cannot serve as an inflation hedge. The bank mentioned that Bitcoin keeps trading in tandem with the U.S. stocks despite being promoted as a haven asset.
Forex And Cryptocurrencies Forecast For May 9-13
Article By:
Roman Butko
Read
Saturday, May 7, 2022 5:45 PM EDT
The market felt that the Fed was not aggressive enough, and trading on US stock exchanges on Thursday, May 5 ended with a rise, pulling cryptocurrency quotes along with it. However, the jubilation of risk asset advocates was short-lived.
Darling Ingredients: Chick-Fil-A To Valero
Article By:
MoneyShow.com
Read
Saturday, May 7, 2022 5:25 PM EDT
Darling Ingredients is probably the only company that primarily creates feedstock and fuel from waste animal and oils. It’s not exactly an appealing business to think about, but it’s a unique and fascinating enterprise.
Treasury Snapshot: 10-Year At 3%
Article By:
Jill Mislinski
Read
Saturday, May 7, 2022 5:00 PM EDT
The yield on the 10-year note ended May 6, 2022, at 3.12%, the 2-year note ended at 2.72%, and the 30-year ended at 3.23%. Let's take a closer look.
Gold Price Rebound Vulnerable To Slowdown In US Consumer Prices
Article By:
David Song
Read
Saturday, May 7, 2022 4:44 PM EDT
The price of gold extends the advance from the monthly low ($1851) as the Federal Reserve lays out a preset path for monetary policy. Yet the update to the US Consumer Price Index may rattle the recent rebound in bullion.
Should You Get The KOLD ETF This Spring?
Article By:
Keith Schaefer
Read
Saturday, May 7, 2022 4:30 PM EDT
I want to tell you that you should short natural gas. I want to tell you that the $8.50/mcf natural gas we saw is crazy, that the price is going to come down. I want to tell you this because what I have seen is telling me this is the perfect setup.
Here Is How Elon Musk Aims To Quintuple Twitter's Revenue By 2028
Article By:
Benzinga
Read
Saturday, May 7, 2022 3:59 PM EDT
Tesla Inc CEO Elon Musk has assured Twitter Inc investors that he could increase the company's revenue by many folds within just a couple of years. Musk aims to increase Twitter's annual revenue to $26.4 billion by 2028, up from $5 billion last year.
In this article: TSLA
How To Build An Income-Focused Equity Portfolio With ETFs
Article By:
Zacks Investment Research
Read
Saturday, May 7, 2022 3:44 PM EDT
The current bond market has left investors scurrying for alternative investment options that offer good yields. Investors have also started to reconsider the traditional 60/40 portfolio model. Let's take a look at ETFs that may help this prospect.
Investors Pour Money Into Lipper General U.S. Treasury Funds Despite Performance
Article By:
Lipper Alpha Insight
Read
Saturday, May 7, 2022 3:30 PM EDT
With the poor performance of longer-dated Treasury bonds already realized, inflationary fears growing, and the rising rates environment in place, the question stands: Why have longer-dated U.S. Treasury Funds attracted so much capital this week?
US Dollar Forecast: Focus Now Shifts To CPI Data And A Slew Of Fedspeak Ahead
Article By:
DailyFX
Read
Saturday, May 7, 2022 3:14 PM EDT
The US dollar experienced some volatile performance this past week, as all eyes were on the Fed. The central bank delivered, raising benchmark lending rates by 50-basis points. As traders digested the information, the US dollar regained its footing.
In this article: UUP
Big Bets On Bank Stocks
Article By:
MoneyShow.com
Read
Saturday, May 7, 2022 2:45 PM EDT
Here, we provide an updated outlook on two leading bank stocks. Let's take a look at their performance and see if they're good bets to take in this volatile market.
Week In Review: OrbiMed Plans To Raise $1.1 Billion For Fifth Asia Fund
Article By:
ChinaBio® Today
Read
Saturday, May 7, 2022 2:14 PM EDT
One year after raising $3.5 billion for three funds in 2021, OrbiMed, the world’s largest healthcare-dedicated investor, is back with plans for $4.75 billion in new funds despite the slowdown in biopharma exits over the past year.